MYOS RENS TECHNOLOGY INC. MYOS Income Statement

Myos rens technology inc. (MYOS)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Net revenues
1,173	1,032	802	518	452	360	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net revenues
-	-	-	-	-	-	-	-	-	-	-	-	282	327	335	332	348	159	135	206	1,803	3,343	4,739	5,550	4,586	3,318	2,087	1,535	1,164	911	777	467	124	99	55	0	0	0	0
Cost of revenues
494	397	412	297	278	248	216	222	204	308	271	236	241	319	640	1,006	988	780	570	406	1,020	1,420	1,930	2,126	1,799	1,521	1,080	1,006	981	863	679	351	58	49	26	0	0	0	-
Gross profit
679	635	390	221	174	112	152	240	229	218	125	39	41	8	-305	-674	-640	-621	-435	-200	783	1,923	2,809	3,424	2,787	1,797	1,007	529	183	48	98	116	65	49	29	0	0	0	-
Operating expenses:
Selling, marketing and research
1,203	1,276	1,088	877	775	894	980	943	916	822	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	888	1,022	1,103	1,348	1,207	949	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Personnel and benefits
1,945	1,897	1,853	1,843	1,721	1,718	1,558	1,471	1,534	1,450	1,835	1,807	1,795	1,853	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
1,639	1,680	1,663	1,713	1,758	1,829	1,849	1,909	1,937	2,014	1,845	1,784	1,674	1,616	0	0	0	-	-	-	-	-	-	-	0	-	0	0	-	3,084	3,008	3,354	3,373	4,645	3,731	2,347	0	0	0
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,305	5,345	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of acquired intangibles
-	-	-	-	-	-	-	-	-	-	-	-	-	-	210	210	210	210	208	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bad debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss on asset impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	44	44	44	0	0	5	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on asset impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
4,787	4,853	4,604	4,433	4,254	4,441	4,387	4,323	4,387	4,286	3,865	3,877	4,261	4,315	4,544	4,609	4,103	4,441	4,937	6,060	7,093	7,128	7,818	7,038	6,385	6,064	0	0	0	-	-	-	-	-	-	-	-	-	-
Operating loss
-4,108	-4,218	-4,214	-4,212	-4,080	-4,329	-4,235	-4,083	-4,158	-4,068	-3,740	-3,838	-4,220	-4,307	-4,849	-5,283	-4,743	-5,062	-5,372	-6,260	-6,310	-5,205	-5,008	-3,613	-3,597	-4,267	-3,880	-4,146	-3,704	-3,035	-2,910	-3,237	-3,307	-4,596	-3,702	-2,347	0	0	0
Other expense:
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	778	801	814	819	46	24	13	8	0	0	0
Other expense, net
0	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Other (expense) income
-	-	-	-	-	-	-	-	-	12	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	2	2	3	3	4	6	11	10	8	5	0	0	-	0	-	-	-	-
Interest expense
-	-	0	-	-	-	0	-	-	-	0	-	-	35	38	32	26	15	11	6	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Value of warrants in excess of the amount of additional paid-in capital received in the related private placement of restricted common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,373	-2,405	-2,405	-2,405	-32	0	0	0	0
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-34	-16	-3,250	-2,031	0	-	0	0	-	0	-
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0
Impairment charge - intellectual property
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	2,662	2,662	2,662	2,662	0	0	0	-	-
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35	69	-402	-402	44	10	0	0	0	-	-
Gain on forgiveness of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Total other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-34	-38	-31	-25	-14	0	0	0	-	-	-	3	4	7	241	-801	-878	-2,718	279	-614	-1,001	834	-2,398	0	0	0
Loss before income taxes
-	-	0	0	-	-	0	0	-	-	-	0	-	-	-	-5,314	-4,768	-5,076	-5,386	-6,270	-6,313	-5,207	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	2	-746	-747	-747	-748	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-4,149	-4,258	-3,136	-3,126	-2,985	-3,223	-4,240	-4,082	-4,154	-4,058	-3,728	-3,841	-4,238	-4,341	-4,887	-5,315	-4,769	-5,078	-4,640	-5,523	-5,566	-4,459	-5,006	-3,610	-3,594	-4,263	-3,873	-3,904	-4,505	-3,914	0	0	0	-	-	-	-	-	-
Deemed dividend resulting from warrant modification
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common shareholders:
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common shareholders:
Weighted average number of common shares outstanding, basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	53,454	49,000,000	49,000
Basic and diluted
-0.09	-0.10	-0.10	-0.13	-0.13	0.00	-0.12	-0.14	-0.19	-0.17	-0.13	-0.19	-0.20	-0.12	-0.17	-0.30	-0.31	-0.38	-0.39	-0.37	-0.50	-0.31	-0.75	-0.34	-0.16	-0.67	-0.35	-0.44	-0.47	-2.09	-0.01	-0.02	-0.01	-0.04	0.03	-0.04	-0.04	0.00	0.00
Weighted average number of common shares outstanding:
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,867	-4,746	0	0	0
Basic and diluted
9,717	9,200	9,173	9,170	7,669	7,329	7,473	7,249	6,504	6,184	5,844	5,844	5,627	-9,040	5	5,057	3,997	-6,478	3,306	3,182	3	5,614	2,886	2,909	2	4,336	2,218	2	2,295	-250,467	106,387	79,944	71,495	-	65,476	61,317	-	-	-